67
Participants
Start Date
September 30, 2015
Primary Completion Date
November 25, 2019
Study Completion Date
November 25, 2019
MGD009
B7-H3 x CD3 DART protein
Saint Vincent's Hospital Sydney, Darlinghurst
Chris O'Brien Lifehouse, Camperdown
Austin Health, Heidelberg
Princess Alexandra Hospital, Woolloongabba
Linear Clinical Research, Nedlands
New York University, New York
Columbia University Medical Center, New York
Penn Presbyterian Medical Center, Philadelphia
Georgetown University, Washington D.C.
Virginia Cancer Specialists, Fairfax
Carolina BioOncology Institute, Huntersville
Henry-Joyce Cancer Center, Nashville
Mary Crowley Cancer Research Center, Dallas
South Texas Accelerated Research Therapeutics, LLC, San Antonio
UCLA, Los Angeles
University of California - San Francisco, San Francisco
Stanford University School of Medicine, Palo Alto
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Princess Margaret Cancer Centre, Toronto
Lead Sponsor
MacroGenics
INDUSTRY